Development and evaluation of the screening performance of a low-cost high-risk screening strategy for breast cancer

Yubei Huang; Huan Wang; Zhangyan Lyu; Hongji Dai; Peifang Liu; Ying Zhu; Fengju Song; Kexin Chen

doi:10.20892/j.issn.2095-3941.2020.0758

Article Information

20200758

DOI

https://doi.org/10.20892/j.issn.2095-3941.2020.0758

Published By

Cancer Biology & Medicine

History

Received December 9, 2020
Accepted April 6, 2021
Published online July 15, 2022.

Article Versions

You are currently viewing a previous version of this article (July 15, 2022 - 07:16).
View the most recent version of this article

Copyright: © 2021, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

Yubei Huang1,*,
Huan Wang1,*,
Zhangyan Lyu1,
Hongji Dai1,
Peifang Liu2,
Ying Zhu2,
Fengju Song1 and
Kexin Chen1 ⇑

¹Department of Cancer Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Molecular Epidemiology of Tianjin, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Tianjin 300060, China
²Department of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Molecular Epidemiology of Tianjin, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Tianjin 300060, China